STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Medical Devices
trading-chart

Doximity Reports Strong Q3 Earnings with 25% Revenue Growth

byLuca Blaumann
February 7, 2025
in Medical Devices, Mid-Cap
Reading Time: 3 mins read
Share on TwitterShare on LinkedIn

AI Tools and Provider Engagement Drive Record Performance

Doximity (DOCS), the leading digital platform for U.S. medical professionals, reported strong fiscal 2025 third-quarter results, showcasing significant growth in revenue, net income, and adjusted EBITDA. For the quarter ended December 31, 2024, the company delivered total revenue of $168.6 million, marking a 25% year-over-year increase from $135.3 million in the same period last year.

“We’re proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools,” said Jeff Tangney, co-founder and CEO of Doximity. “Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers.”

Financial Highlights

  • Revenue: $168.6 million, up 25% from $135.3 million in Q3 FY2024.
  • Net Income: $75.2 million, reflecting a 57% increase from $48.0 million.
  • Non-GAAP Net Income: $91.4 million, up from $58.5 million, with a margin improvement to 54.2%.
  • Adjusted EBITDA: $102.0 million, an increase of 39% from $73.3 million, with adjusted EBITDA margins reaching 60.5%.
  • Diluted EPS: $0.37 per share, compared to $0.24 per share in the previous year.
  • Operating Cash Flow: $65.2 million, reflecting a 30% growth from $50.1 million.
  • Free Cash Flow: $63.4 million, up from $48.7 million, also representing a 30% increase.

Growth Drivers and AI Expansion

Doximity’s robust performance was fueled by increasing adoption of its AI-driven tools, which saw a remarkable 60% growth in the quarter. Additionally, its newsfeed feature surpassed one million unique providers, underlining the platform’s expanding engagement and utility for medical professionals.

Financial Outlook

Looking ahead, Doximity provided guidance for its fiscal fourth quarter ending March 31, 2025:

  • Revenue: Expected between $132.5 million and $133.5 million.
  • Adjusted EBITDA: Forecasted between $62.5 million and $63.5 million.

For the full fiscal year 2025, the company revised its projections:

  • Revenue: Estimated between $564.6 million and $565.6 million.
  • Adjusted EBITDA: Expected between $306.6 million and $307.6 million.

Doximity’s continued investment in AI tools and digital engagement solutions positions the company for sustained growth. With strong financial performance and increasing adoption among healthcare professionals, the company remains a key player in the digital health space.

You might like this article:Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development

Tags: DOCSDoximityEarningsGrowthMoversNewsStock Market
Previous Post

Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development

Next Post

Strategy Resumes Aggressive Bitcoin Buying, Now Holds $47 Billion in Crypto

Related Posts

Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance

byLuca Blaumann
October 28, 2025
0

Robust operational performance, $225 million in revenue, and expanded bonding capacity position Orion for sustained growth Orion Group Holdings (ORN),...

Co-Diagnostics Expands Global Reach with New Saudi Joint Venture

byLuca Blaumann
October 27, 2025
0

CoMira Diagnostics to Localize PCR Manufacturing and Healthcare Innovation Across KSA and 18 MENA Countries Co-Diagnostics (CODX), a leading molecular...

investing

Datavault AI and Wellgistics Partner to Revolutionize Prescription Tracking with Blockchain Technology

byLiliana Vida
October 24, 2025
0

Collaboration aims to enhance transparency, efficiency, and patient safety through smart contract integration Datavault AI (DVLT), a leader in AI-powered...

Next Post
bitcoin-1

Strategy Resumes Aggressive Bitcoin Buying, Now Holds $47 Billion in Crypto

Latest News

Alphabet Tops $100 Billion Quarter as AI Cloud Deals Power Record Growth

Microsoft Reports Strong Q3 Results Driven by Cloud and AI Momentum

Meta Beats on Revenue, Misses EPS as One-Time Tax Charge Weighs on Q3

Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240

Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance

Based on Your Interest

nvidia-chip
Artificial Intelligence

Nvidia Partners with U.S. Department of Energy to Build Seven AI Supercomputers

October 28, 2025
investing
Artificial Intelligence

Qualcomm Enters the AI Data Center Battle with Powerful New AI200 and AI250 Chips

October 27, 2025
Biotechnology

Co-Diagnostics Expands Global Reach with New Saudi Joint Venture

October 27, 2025

Recommended

Artificial Intelligence

Datavault AI and Wellgistics Partner to Revolutionize Prescription Tracking with Blockchain Technology

October 24, 2025
Large-Cap

AMD Shares Surge as IBM Taps Its Chips for Quantum Computing Breakthrough

October 24, 2025
Large-Cap

Intel Surges After Strong Q3 Earnings Beat, But Manufacturing Challenges Remain

October 23, 2025
Auto Manufacturers

Ford Beats Q3 Estimates but Cuts 2025 Outlook Following Supplier Fire

October 23, 2025
Biotechnology

Scienture Launches Commercial Sales of Arbli™, the First FDA-Approved Ready-to-Use Losartan Suspension

October 23, 2025
Stoxpo

Follow us on social media:

Highlights

  • Alphabet Tops $100 Billion Quarter as AI Cloud Deals Power Record Growth
  • Microsoft Reports Strong Q3 Results Driven by Cloud and AI Momentum
  • Meta Beats on Revenue, Misses EPS as One-Time Tax Charge Weighs on Q3
  • Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240
  • Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Alphabet Tops $100 Billion Quarter as AI Cloud Deals Power Record Growth

October 29, 2025

Microsoft Reports Strong Q3 Results Driven by Cloud and AI Momentum

October 29, 2025
investing

Meta Beats on Revenue, Misses EPS as One-Time Tax Charge Weighs on Q3

October 29, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.